Health Catalyst delivered Q3 2025 revenue in line with the prior year at $76.3 million, improved adjusted EBITDA by 64%, and enhanced gross margins, despite a GAAP net loss of $22.2 million due to restructuring and lease-related charges.

Health Catalyst delivered a strong performance in Q2 2025, with total revenue reaching $80.7 million and Adjusted EBITDA at $9.3 million, both surpassing the company's guidance. Despite a significant net loss, the company's core operational metrics showed positive growth.

Health Catalyst exceeded its quarterly guidance on both total revenue and Adjusted EBITDA in Q1 2025. The company reported total revenue of $79.4 million, a 6% increase year-over-year, and Adjusted EBITDA of $6.3 million, an 86% increase year-over-year. Net loss increased by 15% to $23.7 million.

Health Catalyst achieved strong performance in Q4 2024, with total revenue reaching $79.6 million and Adjusted EBITDA at $7.9 million, significantly exceeding the previous year's figures. The Technology segment showed notable growth, contributing to the overall positive results.

Health Catalyst reported strong financial results for Q3 2024, with total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, both exceeding the midpoint of their quarterly guidance. They are raising their Adjusted EBITDA guidance by $1 million for 2024.

Health Catalyst reported strong Q2 2024 financial results, with total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, both exceeding the midpoint of the company's quarterly guidance. The company also saw strong bookings performance, signing more net new Platform Subscription Clients in the first half of 2024 than in all of 2023.

Health Catalyst reported a 1% increase in total revenue, reaching $74.7 million for the first quarter of 2024. The company's Adjusted EBITDA was $3.4 million. They are reiterating the full year 2024 total revenue and Adjusted EBITDA guidance ranges and also reiterating both of their bookings metrics, inclusive of dollar-based retention rate and net new DOS Subscription client additions.

Health Catalyst reported a 9% increase in total revenue for Q4 2023, reaching $75.1 million, and a significant improvement in Adjusted EBITDA to $1.4 million. The company also announced leadership changes, with a new CFO and COO effective March 1, 2024.

Health Catalyst reported strong Q3 2023 financial results, with total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, both exceeding the midpoint of their quarterly guidance. They raised their full-year revenue guidance and reiterated their Adjusted EBITDA guidance. Team member engagement scores were also high, measured in the 94th percentile.

Health Catalyst reported total revenue of $73.2 million and Adjusted EBITDA of $3.5 million for the second quarter of 2023, exceeding the mid-point of their quarterly guidance. The company is raising its 2023 revenue and Adjusted EBITDA guidance and reiterating its full year 2023 bookings expectations.

Health Catalyst reported strong first-quarter results, exceeding the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA. The company also announced a meaningful expansion of its tech-enabled managed services partnership with Allina Health, increasing Allina's recurring revenue to approximately $11 million per year.

Health Catalyst reported strong Q4 2022 results, exceeding revenue and Adjusted EBITDA guidance. The company also announced the appointment of Matthew Kolb to its Board of Directors and a deepened investment from Carle Health.

Health Catalyst reported strong Q3 2022 results, exceeding revenue and Adjusted EBITDA guidance. The company raised its full year 2022 revenue and Adjusted EBITDA guidance and expects the dollar-based retention achievement level to be between 97% and 101%.

Health Catalyst reported strong Q2 2022 financial results, exceeding revenue and Adjusted EBITDA guidance. However, the company revised down its revenue and Adjusted EBITDA outlook for the full year due to a challenging end market environment impacting bookings performance.

Health Catalyst reported strong first quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive Adjusted EBITDA, fulfilling a commitment made at the time of its IPO.

Health Catalyst reported strong Q4 2021 performance, exceeding revenue and Adjusted EBITDA guidance. They also reported team member engagement scores in the 96th percentile. For the full year 2021, the company is proud of its financial performance.

Health Catalyst reported strong third-quarter results, exceeding the midpoint of their quarterly guidance for both revenue and Adjusted EBITDA. The company also hosted its annual Healthcare Analytics Summit conference in September, with over 3,000 registrants.

Health Catalyst reported strong second-quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive quarterly Adjusted EBITDA for the first time and closed the acquisition of Twistle, which is expected to enhance the Population Health analytics application suite.

Health Catalyst reported a 24% increase in total revenue compared to the previous year. The company exceeded the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA. Team member satisfaction scores continue to rank in the 96th percentile.

Health Catalyst reported strong Q4 2020 results, exceeding the midpoint of quarterly and full-year guidance for both revenue and Adjusted EBITDA. The company's technology played a key role in supporting customers' pandemic response.

Health Catalyst reported a 20% increase in total revenue to $47.2 million and an adjusted EBITDA of negative $6.4 million for the third quarter of 2020. The company exceeded the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA.

Health Catalyst reported strong financial results for Q2 2020, exceeding revenue and Adjusted EBITDA guidance. Team member satisfaction remained high, and the company is hosting its annual Healthcare Analytics Summit virtually in September.

Health Catalyst reported strong first-quarter results, exceeding expectations for both total revenue and Adjusted EBITDA. The company's performance highlights the increasing need for healthcare organizations to invest in data and analytics, which is expected to drive long-term growth.

Health Catalyst reported strong Q4 2019 results, exceeding the midpoint of its guidance. The company's team member engagement scores were in the 99th percentile, marking the highest achievement in the company's history.